Last reviewed · How we verify
NCT01547520
Meperidine as the Single Sedative Agent During Esophagogastroduodenoscopy, a Double-blind, Randomized Controlled Study
NA trial testing Meperidine in Esophagogastroduodenoscopy in 140 participants. Completed in 1 February 2012.
1 February 2012
Quick facts
| Lead sponsor | Dalin Tzu Chi General Hospital |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | diagnostic |
| Enrollment | 140 |
| Start date | 1 June 2011 |
| Primary completion | 1 February 2012 |
| Estimated completion | 1 February 2012 |
| Sites | 1 location across Taiwan |
Drugs / interventions tested
- Meperidine — full drug profile →
- normal saline
Conditions studied
- Esophagogastroduodenoscopy — all drugs for Esophagogastroduodenoscopy →
Sponsor
Dalin Tzu Chi General Hospital
Who can join
Adults 20 to 65, any sex, with Esophagogastroduodenoscopy. Patients with the condition only — healthy volunteers not accepted.
What's being measured
Primary outcomes are the specific endpoints the trial is designed to prove or disprove.
-
discomfort score during esophageal intubation
Time frame: 9 months
patient self-reported discomfort score during esophageal intubation, assessed with a 0 to 10 visual analog scale (VAS)
Sponsor's own description
Upper endoscopy is uncomfortable for most patients. Meperidine has both sedative and analgesic effects, so its use may be helpful for patients receiving upper endoscopy.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Meperidine as the single sedative agent during esophagogastroduodenoscopy, a double-blind, randomized, controlled study.
Hsieh YH, Lin HJ, Hsieh JJ, Tseng KC, et al · · 2013 · cited 4× · PMID 23431993 · DOI 10.1111/jgh.12183
Verify or expand the search:
- PubMed search for NCT01547520
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Meperidine
Trials testing the same drug.
- NCT05035407 — T Cell Receptor Gene Therapy Targeting KK-LC-1 for Gastric, Breast, Cervical, Lung and Other KK-LC-1 Positive Epithelial · Phase 1 · terminated
- NCT05110469 — Comparison of MgSO4 Versus Meperidine for Prevention of Shivering During Spinal Anesthesia · Phase 4 · completed
- NCT04068948 — Comparing Pediatric Dental Oral Sedation Outcomes With and Without Meperidine in Children Aged 3-7 Years · Phase 4 · completed
- NCT03167905 — CODEPAD (Collaborative Outcomes of DEpression and Pain Associated With Delivery) · Phase 2, PHASE3 · active not recruiting
- NCT02858310 — E7 TCR T Cells for Human Papillomavirus-Associated Cancers · Phase 1, PHASE2 · completed
Other recruiting trials for Esophagogastroduodenoscopy
Currently open trials in the same condition.
- NCT07245095 — Premedication With N-acetylcysteine and Simethicone to Improve Mucosal Visualization in Elective Upper Endoscopy · Phase 2 · recruiting
Other Dalin Tzu Chi General Hospital trials
Trials by the same sponsor.
- NCT07180485 — Effectiveness of Whole Body Vibration on Health Outcomes in Older Adults With Dynapenic Abdominal Obesity · NA · not yet recruiting
- NCT06963125 — The Effects of Prune Juice on Bowel Movement Patterns, Constipation Symptoms, and Quality of Life · NA · recruiting
- NCT06791980 — Integrated Care Approach for Rheumatoid Arthritis Patients · NA · completed
- NCT06344169 — Dinalbuphine Ester (Naldebain) for Pain Management After Cesarean Section · Phase 2, PHASE3 · recruiting
- NCT06875115 — Evaluation of the Efficacy of Laser Acupuncture on Uremic Pruritus · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT01547520 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Dalin Tzu Chi General Hospital
- Last refreshed: 7 March 2012
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01547520.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing